Improving the anti-inflammatory activity of 5-aminosalicylic acid by combination with cyanidin-3-glucoside: An in vitro study - ScienceDirect
Ulcerative Colitis: Achieving and Maintaining Remission
Frontiers | Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice | Immunology
Prokinetic Drugs A gastroprokinetic agent, gastrokinetic, or prokinetic, is a type of drug which enhances gastrointestinal motility by increasing the frequency. - ppt video online download
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Frontiers | Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications | Immunology
Aspirin Mechanism of Action. | Download Scientific Diagram
Mechanism of Action of Aminosalicylates - YouTube
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Carcinogenesis in Ulcerative Colitis | IntechOpen
Drugs used in IBD and biological and immune therapy of IBD ” - ppt download
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
Mechanisms of action of aspirin and clopidogrel. Abbreviations: ASA,... | Download Scientific Diagram
Treatment algorithm of active ulcerative colitis. 5-ASA,... | Download Scientific Diagram
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems - ScienceDirect
Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence - DESREUMAUX - 2006 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
The long journey of salicylates in ulcerative colitis: The past and the future - ScienceDirect
Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor - ScienceDirect
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases | Pharmacology
DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD. - ppt download
Safety of 5-Aminosalicylic Acid Derivatives in Patients with Sensitivity to Acetylsalicylic Acid and Nonsteroidal Anti-inflammatory Drugs
A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems - ScienceDirect
PPARgamma as a new therapeutic target in inflammatory bowel diseases. - Abstract - Europe PMC
Drug Insight: aminosalicylates for the treatment of IBD | Nature Reviews Gastroenterology & Hepatology
New therapeutic avenues in ulcerative colitis: thinking out of the box | Gut
